# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-22-096178
Filing Date
2022-04-05
Accepted
2022-04-05 16:16:08
Documents
3

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | d333563ddefa14a.htm | DEFA14A | 18231
2 | GRAPHIC | g333563g20h20.jpg | GRAPHIC | 411210
3 | GRAPHIC | g333563g21h21.jpg | GRAPHIC | 353729
| Complete submission text file | 0001193125-22-096178.txt |  | 1072921

Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

EIN.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37702 | Film No.: 22807029
SIC: 2836 Biological Products, (No Diagnostic Substances)